Stiller M J, Teperman L, Rosenthal S A, Riordan A, Potter J, Shupack J L, Gordon M A
Department of Dermatology, Harvard University, Boston, MA.
J Am Acad Dermatol. 1994 Aug;31(2 Pt 2):344-7. doi: 10.1016/s0190-9622(94)70169-5.
We report the first case of primary cutaneous aspergillosis caused by Aspergillus ustus, a species that seldom infects human beings. The patient, a 62-year-old liver transplant recipient with end-stage hepatitis C-induced cirrhosis, was receiving the experimental immunosuppressive drug FK-506. Trauma to the skin of the right arm from tape and from an arm board holding intravenous and intraarterial catheters in place and to the left leg from an occlusive knee brace may have contributed to this unusual mycosis. The patient's cutaneous aspergillosis responded to a combination of intravenous amphotericin B and topical terbinafine cream. Although the patient died shortly thereafter from hepatic failure, there was no evidence of systemic aspergillosis.
我们报告了首例由ustus曲霉引起的原发性皮肤曲霉病,该菌种很少感染人类。患者为一名62岁的肝移植受者,患有终末期丙型肝炎引起的肝硬化,正在接受实验性免疫抑制药物FK-506治疗。右臂皮肤因固定静脉和动脉导管的胶带及臂板而受到创伤,左腿因膝关节固定支具而受到创伤,这些可能促成了这种不寻常的真菌病。患者的皮肤曲霉病对静脉注射两性霉素B和外用特比萘芬乳膏的联合治疗有反应。尽管患者此后不久死于肝衰竭,但没有全身曲霉病的证据。